The AIRQ effectively identifies asthma exacerbation risk at 3 months and 12 months among patients with varying levels of asthma severity.

Patients newly diagnosed with IPF at the time of a respiratory-related hospitalization had significantly shorter survival.

President Trump signed an executive order boosting federal research into psychedelic substances and expanding their use in controlled treatment settings.

A new Senate report found that drug companies involved in price deals with Trump have continued to raise prices on hundreds of medications.

The FDA will soon review whether certain peptides should be allowed in customized medications made by compounding pharmacies.

A newly developed DNAm-IgE score using 107 CpGs may identify early epigenetic patterns linked to childhood respiratory morbidity.

Researchers reported favorable safety and tolerability for CS1 after 12 months of treatment in patients with pulmonary arterial hypertension.

Hydrogen sulfide can effectively reverse established hypoxia-induced PH and remodeling of pulmonary vascular structure in a rat model.

Occupational exposure to asbestos-free talc appears not to be linked to increased risk for lung cancer, mesothelioma, or laryngeal cancer.

After months of leadership changes, President Donald Trump has chosen a new candidate, Dr Erica Schwartz, to lead the CDC.

Surgery for early-stage NSCLC is associated with similarly favorable safety and long-term outcomes for octogenarians and for younger patients.

Among men without obesity, COPD-SDB overlap vs SDB alone is linked to increased subclinical atherosclerosis and arterial stiffness.